Patents by Inventor Gudrun BIRK

Gudrun BIRK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240277645
    Abstract: The disclosed technology relates to a continuous impregnating process of active pharmaceutical ingredients (API) onto porous carriers, a continuous impregnation process for making impregnated porous carrier particles and pharmaceutical dosage forms comprising impregnated porous carrier particles, impregnated porous carrier particles and pharmaceutical dosage forms comprising impregnated porous carrier particles prepared by the continuous impregnation process.
    Type: Application
    Filed: June 13, 2022
    Publication date: August 22, 2024
    Applicants: MERCK PATENT GMBH, RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventors: Fernando J. MUZZIO, Benjamin J. GLASSER, Thamer A. OMAR, Andrés D. ROMÁN-OSPINO, Gudrun BIRK
  • Publication number: 20220409543
    Abstract: The present invention provides a method for preparing a pharmaceutical composition of a pharmaceutical ingredient (API) which is loaded on a carrier and stabilized therethrough. In particular, the present invention relates to a composition of a poorly soluble nanoparticulated API on a carrier in the dry state and which is processed as pharmaceutical formulation of said API with improved release profile and bioavailability.
    Type: Application
    Filed: November 27, 2020
    Publication date: December 29, 2022
    Applicant: MERCK PATENT GMBH
    Inventors: Dieter LUBDA, Gudrun BIRK
  • Patent number: 11174218
    Abstract: The present invention relates to compacted glycine granules, where at least 75% of the granules have a particle size of above 0.7 mm, and to a process for the preparation and use of granules of this type.
    Type: Grant
    Filed: January 24, 2017
    Date of Patent: November 16, 2021
    Assignee: Merck Patent GmbH
    Inventors: Harald Benk, Gudrun Birk, Melina Decker, Dieter Lubda, Guenter Moddelmog, Harald Muessig, Tanino Scaramuzza, Michael Schleehahn
  • Patent number: 10874615
    Abstract: The present invention relates to novel pharmaceutical formulations which have controlled, delayed release of active ingredient, and to a process for the preparation of such formulations. The invention additionally relates to the use of these novel pharmaceutical administration forms as medicaments for the treatment of diseases which require delayed release of the active ingredient, such as hypertension, or asthmatic diseases.
    Type: Grant
    Filed: August 25, 2016
    Date of Patent: December 29, 2020
    Assignee: Merck Patent GmbH
    Inventors: Finn Bauer, Thorsten Wedel, Guenter Moddelmog, Gudrun Birk, Roberto Ognibene, Dieter Lubda
  • Publication number: 20200246270
    Abstract: The present invention relates to novel pharmaceutical formulations which have controlled, delayed release of active ingredient, and to a process for the preparation of such formulations. The invention additionally relates to the use of these novel pharmaceutical administration forms as medicaments for the treatment of diseases which require delayed release of the active ingredient, such as hypertension, or asthmatic diseases.
    Type: Application
    Filed: April 21, 2020
    Publication date: August 6, 2020
    Applicant: Merck Patent GmbH
    Inventors: Finn BAUER, Thorsten WEDEL, Guenter MODDELMOG, Gudrun BIRK, Roberto OGNIBENE, Dieter LUBDA
  • Publication number: 20190307698
    Abstract: The present invention relates to tablets having extremely long release of active pharmaceutical ingredient, to the particular composition thereof and to the production thereof.
    Type: Application
    Filed: December 11, 2017
    Publication date: October 10, 2019
    Applicant: Merck Patent GmbH
    Inventors: Gudrun BIRK, Guenter MODDELMOG, Thorsten WEDEL
  • Publication number: 20190047942
    Abstract: The present invention relates to compacted glycine granules, where at least 75% of the granules have a particle size of above 0.7 mm, and to a process for the preparation and use of granules of this type.
    Type: Application
    Filed: January 24, 2017
    Publication date: February 14, 2019
    Applicant: Merck Patent GmbH
    Inventors: Harald BENK, Gudrun BIRK, Melina DECKER, Dieter LUBDA, Guenter MODDELMOG, Harald MUESSIG, Tanino SCARAMUZZA, Michael SCHLEEHAHN
  • Publication number: 20190038562
    Abstract: The present invention relates to novel pharmaceutical formulations which have controlled, delayed release of active ingredient, and to a process for the preparation of such formulations. The invention additionally relates to the use of these novel pharmaceutical administration forms as medicaments for the treatment of diseases which require delayed release of the active ingredient, such as hypertension, or asthmatic diseases.
    Type: Application
    Filed: August 25, 2016
    Publication date: February 7, 2019
    Applicant: Merck Patent GmbH
    Inventors: Finn BAUER, Thorsten WEDEL, Guenter MODDELMOG, Gudrun BIRK, Roberto OGNIBENE, Dieter LUBDA
  • Publication number: 20180250233
    Abstract: The present invention relates to formulations having extended release of active ingredient, comprising an active ingredient from BCS Class I having high solubility and high permeability in a polyvinyl alcohol-containing matrix, from which the active ingredient is released at a controlled rate over a therapeutically relevant time period independently of the composition of the release medium.
    Type: Application
    Filed: August 25, 2016
    Publication date: September 6, 2018
    Applicant: MERCK PATENT GMBH
    Inventors: Finn BAUER, Thorsten WEDEL, Gudrun BIRK, Roberto OGNIBENE, Dieter LUBDA, Guenter MODDELMOG